drugset / Trial / NCT06269432

Precise Antiplatelet THerapy Guided by Platelet Aggregation Function in Ischemic STROKE(PATH-STROKE)

NCT06269432 ↗

Phase 4 Completed 1224 enrolled Sichuan Provincial People's Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

1. Main objective: To explore the efficacy of precise antiplatelet therapy guided by platelet aggregation function in reducing the incidence of 30 day platelet hyperresponsiveness in patients with non-cardiogenic ischemic stroke. 2. Secondary objective: To explore the efficacy and safety of antiplatelet therapy in patients with non-cardiogenic ischemic stroke under the guidance of platelet aggregation function.

Timeline

Start
2023-01-01
Primary completion
2024-09-30
Completion
2025-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 100 mg Oral
Subject Clopidogrel Small molecule 75 mg —
Subject Ticagrelor Small molecule 90 mg —

Indications